Skip to main content
. 2023 Sep 13;15(18):4544. doi: 10.3390/cancers15184544

Figure 3.

Figure 3

Percentages of patients below, in the interval, and above their individualized HbA1c targets at baseline and 6 months after chemotherapy initiation.